KRAS and disorder of glycogen metabolism: More recently, a mouse model with an activating KRAS (Kirsten rat sarcoma viral oncogene homolog) mutation, designed to replicate a mutation identified in a patient with GSD, also exhibited lymphatic vessel development within the bone marrow space, but whether bone loss occurred is not known (211).